Lara-Marquez, M L <br/><br/>
Vasoactive intestinal peptide (VIP) receptor type 2 (VPAC2) is the predominant receptor expressed in human thymocytes.  [electronic resource] 

 -  Annals of the New York Academy of Sciences  2000 
 - 45-54 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0077-8923 
<br/><br/><label>Standard No.: </label>10.1111/j.1749-6632.2000.tb06950.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>CD4-Positive T-Lymphocytes--immunology<br/>CD8-Positive T-Lymphocytes--immunology<br/>Down-Regulation<br/>Gene Expression<br/>Humans<br/>In Vitro Techniques<br/>Lymphocyte Activation<br/>Monocytes--metabolism<br/>RNA, Messenger--genetics<br/>Receptors, Vasoactive Intestinal Peptide--genetics<br/>Receptors, Vasoactive Intestinal Peptide, Type II<br/>Receptors, Vasoactive Intestinal Polypeptide, Type I<br/>Reverse Transcriptase Polymerase Chain Reaction<br/>T-Lymphocyte Subsets--immunology<br/>T-Lymphocytes--immunology